DK286486A - 1,4-dihydropyridiner, fremgangsmaade til fremstilling deraf samt deresanvendelse i laegemidler - Google Patents

1,4-dihydropyridiner, fremgangsmaade til fremstilling deraf samt deresanvendelse i laegemidler Download PDF

Info

Publication number
DK286486A
DK286486A DK286486A DK286486A DK286486A DK 286486 A DK286486 A DK 286486A DK 286486 A DK286486 A DK 286486A DK 286486 A DK286486 A DK 286486A DK 286486 A DK286486 A DK 286486A
Authority
DK
Denmark
Prior art keywords
dihydropyridines
preparing
medicinal products
alkoxyalkoxy
aralkyloxy
Prior art date
Application number
DK286486A
Other languages
English (en)
Other versions
DK286486D0 (da
Inventor
Siegfried Goldmann
Juergen Stoltefuss
Gerhard Franckowiak
Rainer Gross
Matthias Schramm
Guenter Thomas
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK286486D0 publication Critical patent/DK286486D0/da
Publication of DK286486A publication Critical patent/DK286486A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK286486A 1985-06-19 1986-06-18 1,4-dihydropyridiner, fremgangsmaade til fremstilling deraf samt deresanvendelse i laegemidler DK286486A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853521761 DE3521761A1 (de) 1985-06-19 1985-06-19 Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
DK286486D0 DK286486D0 (da) 1986-06-18
DK286486A true DK286486A (da) 1987-12-20

Family

ID=6273528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK286486A DK286486A (da) 1985-06-19 1986-06-18 1,4-dihydropyridiner, fremgangsmaade til fremstilling deraf samt deresanvendelse i laegemidler

Country Status (14)

Country Link
US (1) US4772612A (da)
EP (1) EP0209701B1 (da)
JP (1) JPH0676380B2 (da)
KR (1) KR870000300A (da)
AT (1) ATE45568T1 (da)
AU (1) AU582247B2 (da)
CA (1) CA1283105C (da)
DE (2) DE3521761A1 (da)
DK (1) DK286486A (da)
ES (1) ES8802498A1 (da)
FI (1) FI83773C (da)
HU (1) HU196371B (da)
IL (1) IL79118A (da)
ZA (1) ZA864538B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DE3833892A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4911559A (en) * 1988-11-01 1990-03-27 Diatek, Inc. Disposable probe cover assembly for medical thermometer
US5066142A (en) * 1990-03-08 1991-11-19 Ivac Corporation Protective apparatus for a biomedical probe
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
DK55192D0 (da) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindenderivater
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
DE4430092A1 (de) * 1994-08-25 1996-02-29 Bayer Ag 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6292685B1 (en) * 1998-09-11 2001-09-18 Exergen Corporation Temporal artery temperature detector
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
JPS6056956A (ja) * 1983-09-08 1985-04-02 Shoichiro Ozaki １，４−ジヒドロピリジン誘導体及びその製法
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
FI83773C (fi) 1991-08-26
IL79118A (en) 1990-01-18
FI83773B (fi) 1991-05-15
DK286486D0 (da) 1986-06-18
JPH0676380B2 (ja) 1994-09-28
JPS61291567A (ja) 1986-12-22
AU582247B2 (en) 1989-03-16
EP0209701B1 (de) 1989-08-16
DE3665060D1 (en) 1989-09-21
CA1283105C (en) 1991-04-16
HUT42068A (en) 1987-06-29
US4772612A (en) 1988-09-20
FI862584A (fi) 1986-12-20
HU196371B (en) 1988-11-28
ZA864538B (en) 1987-02-25
DE3521761A1 (de) 1987-01-02
ES8802498A1 (es) 1988-07-01
KR870000300A (ko) 1987-02-17
ATE45568T1 (de) 1989-09-15
ES556180A0 (es) 1988-07-01
FI862584A0 (fi) 1986-06-17
EP0209701A3 (en) 1987-07-01
EP0209701A2 (de) 1987-01-28
IL79118A0 (en) 1986-09-30
AU5897886A (en) 1986-12-24

Similar Documents

Publication Publication Date Title
DK286486A (da) 1,4-dihydropyridiner, fremgangsmaade til fremstilling deraf samt deresanvendelse i laegemidler
DE3365772D1 (en) 1,4-dihydropyridines, process for their preparation and their application as pharmaceutical preparations
FI881103A0 (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
SE8701348L (sv) Forbettringar av farmaceutiskt godtagabara salter
NO871640D0 (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
FI874459A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
PT83451A (pt) Process for the preparation of derivatives of quinoline benzothiazole and analogous thereof
FI873350A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
IL84894A0 (en) Resolution of 1,4-dihydropyridine derivatives and optically active derivative salts of such derivatives
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
NO159852C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive derivater av piperidindion.
FI890477A (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
ATE40554T1 (de) Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung.
FI883782A (fi) Menetelmä titaanidioksidipigmentin valmistamiseksi
FI854512A0 (fi) Ny kristallform av benzotiazin-dioxidsaltet.
DE3671624D1 (de) Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung.
ATE122340T1 (de) Verfahren zur herstellung von (-)2-(2-(2- aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl - 3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4 dihydropyridin, und zwischenprodukt zu dessen herstellung.
DE68920493D1 (de) Verfahren zur Herstellung von Derivaten von 2'-Deoxy-beta-cytidin und Salze davon.
DE69027318D1 (de) Eintopfverfahren zur Herstellung des alpha-L-Aspartyl-L-Phenylalaninmethylesters
DK0461218T3 (da) Præparat af et salt af oxypurinol i oral form til behandling af hyperurikæmi
CS486586A1 (en) 2-(2-furykvinylene)-3-substituted benzothiazole salts and method of their preparation
SG144094G (en) Oral formulation of buspirone and salts thereof
MA21436A1 (fr) Variete nouvelle de rosier de la classe des hybrides de the aux fleurs blancs-vert seve tres clair en boutons "jacster"

Legal Events

Date Code Title Description
ATS Application withdrawn